Lixiang Ren

708 total citations
13 papers, 614 citations indexed

About

Lixiang Ren is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Lixiang Ren has authored 13 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in Lixiang Ren's work include Cancer therapeutics and mechanisms (3 papers), Biological and pharmacological studies of plants (3 papers) and Bioactive natural compounds (3 papers). Lixiang Ren is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Biological and pharmacological studies of plants (3 papers) and Bioactive natural compounds (3 papers). Lixiang Ren collaborates with scholars based in China. Lixiang Ren's co-authors include Yifan Luo, Dawei Chen, Jing Qin, Xiuli Zhao, Yingliang Wu, Ping Gong, Guoliang Chen, Wei Shan, Xia Li and Daiying Zuo and has published in prestigious journals such as Journal of Controlled Release, European Journal of Medicinal Chemistry and Biological and Pharmaceutical Bulletin.

In The Last Decade

Lixiang Ren

12 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lixiang Ren China	10	244	243	130	76	55	13	614
Izzeddin Alsalahat United Kingdom	14	164 0.7×	204 0.8×	57 0.4×	27 0.4×	70 1.3×	22	555
Yogesh B. Pawar India	12	188 0.8×	273 1.1×	54 0.4×	80 1.1×	69 1.3×	15	691
Biyun Huang China	12	180 0.7×	72 0.3×	135 1.0×	43 0.6×	45 0.8×	20	494
Mei‐Na Jin China	14	268 1.1×	283 1.2×	70 0.5×	41 0.5×	74 1.3×	33	719
Lizette Auezova Lebanon	12	174 0.7×	102 0.4×	62 0.5×	159 2.1×	19 0.3×	15	549
Zhengjie Fang China	5	142 0.6×	81 0.3×	61 0.5×	58 0.8×	25 0.5×	6	473
Xiaohong Liu China	15	210 0.9×	381 1.6×	52 0.4×	45 0.6×	30 0.5×	26	768
Rebecca L. Edwards United States	10	297 1.2×	64 0.3×	58 0.4×	75 1.0×	78 1.4×	15	858
Tianhong Zhang China	15	223 0.9×	228 0.9×	32 0.2×	34 0.4×	52 0.9×	32	616
Chul-Soon Yong South Korea	16	187 0.8×	301 1.2×	93 0.7×	66 0.9×	149 2.7×	30	714

Countries citing papers authored by Lixiang Ren

Since Specialization

Citations

This map shows the geographic impact of Lixiang Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixiang Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixiang Ren more than expected).

Fields of papers citing papers by Lixiang Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixiang Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixiang Ren. The network helps show where Lixiang Ren may publish in the future.

Co-authorship network of co-authors of Lixiang Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Lixiang Ren. A scholar is included among the top collaborators of Lixiang Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixiang Ren. Lixiang Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ren, Lixiang, Mingwei Wu, & Jiang Xiong. (2023). [Preliminary progress in the study of the relationship between COVID-19 infection and partial arterial or venous diseases].. PubMed. 61(12). 1119–1123.

Luo, Yifan, Lixiang Ren, Mingyan Jiang, & Yang Chu. (2019). Anti-hypertensive efficacy of amlodipine dosing during morning versus evening: A meta-analysis. Reviews in Cardiovascular Medicine. 20(2). 91–91. 13 indexed citations

Xu, Chen, Xiaohui Ji, Gang Hu, et al.. (2014). Design and optimization of novel 4-(2-fluorophenoxy)quinoline derivatives bearing a hydrazone moiety as c-Met kinase inhibitors. European Journal of Medicinal Chemistry. 87. 508–518. 27 indexed citations

He, Chao, et al.. (2014). Design, synthesis and structure–activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents. European Journal of Medicinal Chemistry. 83. 581–593. 33 indexed citations

Liu, Mingmei, et al.. (2014). Design, synthesis and pharmacological evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents. Bioorganic Chemistry. 57. 30–42. 31 indexed citations

Xie, Lijun, Xin Zhai, Lixiang Ren, et al.. (2011). Design, Synthesis and Antitumor Activity of Novel Artemisinin Derivatives Using Hybrid Approach. Chemical and Pharmaceutical Bulletin. 59(8). 984–990. 26 indexed citations

Zhang, Weige, Rui Zhao, Lixiang Ren, et al.. (2007). Synthesis and Anti‐proliferative in‐vitro Activity of Two Natural Dihydrostilbenes and their Analogues. Archiv der Pharmazie. 340(5). 244–250. 21 indexed citations

Ren, Lixiang, et al.. (2007). Antidepressant activity of sarsasapogenin from Anemarrhena asphodeloides Bunge (Liliaceae).. PubMed. 62(1). 78–9. 15 indexed citations

Zhang, Weige, Rui Zhao, Lixiang Ren, et al.. (2007). Synthesis and anti‐Proliferative in vitro Activity of Two Natural Dihydrostilbenes and Their Analogues.. ChemInform. 38(36). 1 indexed citations

10.

Luo, Yifan, Dawei Chen, Lixiang Ren, Xiuli Zhao, & Jing Qin. (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. Journal of Controlled Release. 114(1). 53–59. 330 indexed citations

11.

Ren, Lixiang, Yifan Luo, Xia Li, Daiying Zuo, & Yingliang Wu. (2006). Antidepressant-Like Effects of Sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae). Biological and Pharmaceutical Bulletin. 29(11). 2304–2306. 52 indexed citations

12.

Chen, Guoliang, et al.. (2005). Synthesis and Anti-inflammatory Activity of Resveratrol Analogs. Chemical and Pharmaceutical Bulletin. 53(12). 1587–1590. 60 indexed citations

13.

Zhang, Hao, et al.. (2001). [Study on active constituents of traditional Chinese medicine reversing multidrug resistance of tumor cells in vitro].. PubMed. 24(9). 655–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact